“We did not meet primary endpoint, however there the secondary endpoints showed that this drug is better than any other therapeutic that has been approved to date.”
To be clear, the secondary endpoints failed as well. Yes, one of the secondary endpoints was stat sig among the 62 critical patients, but the FDA is not going to approve a drug based on a subset of of the initial protocol that’s n is 62.
News 
Market Data 
Discover 
AI
